Navigation Links
Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Date:9/26/2011

or complete mastectomy and merits further evaluation," stated Dr. Paul Goldfarb, OncoSec's Medical Director.

Preliminary:  Phase IV Head & Neck Cancer

This Phase IV registration trial carried out in Europe enrolled 92 patients (53 males and 39 females) with 66 patients followed for up to two years. Mean age at enrollment was 61.0 years (range 20 – 86 years). Seventy-six percent of tumors treated were primary cancers, and 23% were recurrent cancers, with a mean tumor volume for all cancers of 19 cm3. Treatment was found to be safe and well-tolerated with majority of adverse events being pain (77%), infection (50%), edema (48%), and dysphagia (30%). Patient survival following treatment at 8 months was 95% (87/92) and 86% (79/92) at 24 months. In addition, 83% (19/23) of patients with primary tumors treated with bleomycin and electroporation alone at 8 months were disease free. The mean time to onset of recurrence was 379 and 276 days for primary and recurrent disease, respectively. Preliminary analysis of this data demonstrates that the primary endpoint, local control of the tumor at 8 months, was achieved.

A subset of the study results from this Phase IV Recurrent and Primary Cutaneous Head & Neck Cancer Study was published by investigators from Orebro University Hospital in Orebro, Sweden in the medical journal Dermatological Surgery, August 2010, in a paper entitled, "Electroporation Therapy of Skin Cancer in the Head and Neck Area." A second subset of results from this study was more recently published by the same group of investigators in the journal Acta Oto-Laryngologica, June 2011, in a paper entitled, "Electroporation therapy for T1 and T2 oral tongue cancer."

Dr. Lennart Lofgren, principal investigator at Obrebro University Hospital and author of the above mentioned articles, said, "OMS ElectroChemotherapy™ has demonstrated promising safety and efficacy results
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay
2. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
3. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
4. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
5. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
6. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
7. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
8. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
9. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it ... Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder and ... proud that our quality of service has been recognized ... lifesaving support and continuity of care to patients of ... the United States ." NeuroCall ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum Materials ... volume production of photoactive quantum dots for use ... While offering numerous advantages for solar power generation, ... quantities of quantum dots with which to develop ... them from commercial utilization and acceptance. The company ...
(Date:10/1/2014)... Sophia Genetics, leader européen ... l,analyse des données issues du SNG (séquençage nouvelle ... in vitro (IVD) du gène CFTR permettant aux ... dans un seul essai SGN. La solution CE-IVD ... de variantes par l,intermédiaire d,un seul essai SGN, ...
Breaking Medicine Technology:NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3
... SADDLE BROOK, N.J., April 27, 2011 Okay, so ... day, but these two working moms are certainly creating ... two high-achieving working moms with formidable educational credentials on ... entrepreneurial detour, something truly unexpected happened...they started selling the ...
... 27, 2011 Wolters Kluwer Health, a leading ... and institutions in medicine, nursing, allied health and pharmacy, ... to acquire Lexi-Comp, Inc., a leading global provider of ... The acquisition is the latest in a series of ...
Cached Medicine Technology:Not Your Average Working Moms 2Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 2Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 3Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 4
(Date:10/1/2014)... Insuranceragents.info has released a new blog ... plan for vulnerable family members. , Life insurance plans ... in the family should always carry a life insurance ... the rest of the family. , Clients can ... more from temporary coverage or from a permanent policy. ...
(Date:10/1/2014)... First Warning Systems, a pioneer in early ... the body, announced the company is changing its name ... breadth of upcoming product releases. The initial focus will ... “Our initial focus will be an ‘Internet of Everthing,’ ... cellular changes over time,” said Rob Royea, president and ...
(Date:10/1/2014)... Farmington Company today announced it ... and visual identity helping brokers, consultants and companies ... to create greater benefit communication synergies. They unveiled ... empowering customers to better leverage Farmington Company’s industry-tested ... of the rebrand is the refreshed tagline: For ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 Beverly ... Dr. Kathleen Mojas is celebrating 20 years of private ... assisted hundreds of people to achieve greater joy and ... important list of warning signs and suggestions for anyone ... Dr. Mojas explains: “Believe it or not, it’s ...
(Date:10/1/2014)... Diet Doc understands that many of their ... and their dieting attempts could be easily sabotaged by the ... diet treatments into their programs as a way to ... and effective weight loss results, it also allows patients to ... maintain their weight for the future. , Earlier versions of ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... rules for the first time forced players to limit the ... had to strategize how pitchers were used more carefully. ... under could throw up to six innings per week and ... in reported cases of young pitchers experiencing arm and shoulder ...
... 4 Health information,technology (HIT) is a powerful ... it must be implemented to interact with other ... to a new report by,BearingPoint, prepared for the ... a nonpartisan independent body based in Washington,but overseen ...
... Oct. 4 Hooper Holmes,(Amex: HH ) ... training,program for all paramedical examiners who have not ... training system,will be rolled out in November with ... same high quality education and training from the ...
... - Data Presented This Week at Major Medical Meeting Reinforce ... Broader Spectrum Pneumococcal ... division of Wyeth (NYSE: WYE ), comments on studies ... the Infectious Diseases,Society of America (IDSA) concerning PREVNAR(R) (Pneumococcal 7-valent,Conjugate ...
... Oct 4 Anesiva, Inc.,(Nasdaq: ANSV ) ... for the,investment community to review the company,s launch ... injection system. The briefing will take place on ... Eastern Time in New York City. To,access the ...
... Growth, ALISO VIEJO, Calif., Oct. 4 ... and services resource for,pathologists, oncologists and the pharmaceutical ... veteran Michael J. Pellini,M.D. has been named Chief ... to President and Chief Executive Officer,Ronald A. Andrews, ...
Cached Medicine News:Health News:How pitching changes little leaguers' shoulders 2Health News:How pitching changes little leaguers' shoulders 3Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 2Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 3Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 4Health News:Portamedic Launches New Examiner Training Program 2Health News:Portamedic Launches New Examiner Training Program 3Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 2Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 3Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 4Health News:Anesiva to Unveil Zingo(TM) Commercialization Plans 2Health News:Clarient Names Michael J. Pellini, M.D. Chief Operating Officer 2Health News:Clarient Names Michael J. Pellini, M.D. Chief Operating Officer 3Health News:Clarient Names Michael J. Pellini, M.D. Chief Operating Officer 4
... femoral option and tibial insert which provides a ... degrees of flexion to induce a smooth stable ... of flexion. Femoral component comes in a PS ... constrained tibial insert in conjunction with the femur ...
... True to its leadership role within the ... clinical experience of the industry's leading fixed-bearing ... Knee System, with the clinically proven technology ... leading rotating platform knee. ,The result is ...
... The Femoral component of ... soft tissue and bony destruction ... a high rate of long ... for minimum bone resection and ...
... Knee System is taking total knee replacement to ... of clinical experience. One thing has become clear ... several choices for their patients. Surgeon choice ... factor in long-term patient satisfaction. Biomet responded to ...
Medicine Products: